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Abstract
Background: Autonomic dysregulation associated with obstructive sleep apnea (OSA) may limit cardiopulmonary
responses to exercise, which, in turn, may impair functional aerobic capacity (FAC) and walking economy. We
aimed to characterize walking economy and FAC in OSA patients compared with healthy adults (non-OSA) and
examine their relationship with OSA severity (apnea-hypopnea index [AHI]).
Methods: A total of 26 adults (OSA, n = 13; non-OSA, n = 13) participated in this cross-sectional study. In this study,
the participants with OSA were between the ages of 25 and 60 years, with a body mass index of 25 kg/m2 to 39 kg/
m2, and who had undergone a recent third-party sleep study with an AHI of 5 or greater. Participants completed a
maximal integrated cardiopulmonary exercise test, three separate exercise bouts of constant work rate (CWR)
treadmill test at 85% of anaerobic threshold (AT), and a 10-min walk test (10MWT). Multiple linear regression
analysis corrected for weight, age, and BMI were performed to examine the associations.
Results: There were significant differences between OSA and non-OSA participants in VO2peak (29.7 ± 5.6 mL/kg/min
vs. 37.5 ± 6.5 mL/kg/min, p = 0.03) and Net VO2 during CWR (12.7 ± 5 vs.19 ± 6 mL/kg/min, p = 0.02). The 10MWT
speed and distance were significantly lower in the OSA group (all p < 0.001). The energy cost of walking during
submaximal exercise and 10-min walk test was higher among patients with OSA (all p < 0.001). The AHI scores were
associated with 10MWT distance (R2 = 0.85, p < 0.001), energy cost of walking (R2 = 87, p < 0.001), and VO2 at
anaerobic threshold (R2 = 0.92, p < 0.001).
Conclusions: The findings of this study show that patients with OSA have reduced FAC and a higher energy cost of
walking. AHI explained 87% of variance in the energy cost of walking during the 10MWT. The results suggest that
individuals with more severe obstructive sleep apnea experience greater impairment in functional performance.
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Background
Walking is the most common form of human physical
activity that requires metabolic energy. It is the outcome
of integration of multiple physiological systems working
together to sustain walking pace for the required metabolic demand. Any impairment in the body system
might have a catastrophic effect on walking economy
and functional aerobic capacity (FAC). Meanwhile,
patients with obstructive sleep apnea (OSA), a repetitive
upper airway obstruction leads to abnormal nocturnal
gas exchange (Guilleminault and Abad 2004), arterial
oxygen desaturation, and chronically elevated sympathoadrenal activity (Carlson et al. 1993; Somers et al.
1995). Furthermore, sleep disorders have been shown to
limit the physical capacity in adults (Puri et al. 2017)
and is commonly associated with significant impairment
in daytime physical functioning, fatigue, and daytime
sleepiness that may limit daily life activities (Aguillard
et al. 1998). By comparison, maximal oxygen consumption is reduced (Mendelson et al. 2018), which indicates
that patients with OSA expend more energy and use a
greater percentage of maximal metabolic capacity when
completing activities of daily living. Despite extensive
and ongoing scientific attention, understanding of the
walking energy cost and mechanical efficiency for a
given submaximal speed of walking in individuals with
OSA have scarcely been studied.
Previous studies on OSA have reported that the presence of OSA negatively influences the aerobic capacity
as measured by maximal oxygen uptake (VO2 max)
(Berger et al. 2019; Lin et al. 2006; Nanas et al. 2010;
Ucok et al. 2009; Vanhecke et al. 2008;Vanuxem et al.
1997). Similarly, OSA severity is associated with an
attenuated rate of oxygen consumption when calculated
using a nomogram based on age, sex, baseline activity
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level, and high post-exercise blood pressure (Mansukhani
et al. 2013). However, it remains unknown whether disease severity, as measured by the apnea hypopnea index
(AHI), is an important predictor of walking economy. As
shown in Fig. 1, the main hypothesis is that patients with
OSA may demonstrate a decline in walking economy and
consequently an increase in the energy cost of walking
indirectly explain by the decline in the functional aerobic
capacity.
To our knowledge, walking performance and net
oxygen consumption during submaximal exercise in
patients with OSA are not clearly determined. Therefore,
the aims of the present study were (1) to characterize
the functional determinants of walking performance and
functional aerobic capacity in individuals with OSA
compared with healthy individuals, and (2) to examine
the relationship between OSA and walking performance
outcomes in people with OSA. Quantification of physiological and functional profile of level walking and during
submaximal exercise may add new and clinically meaningful perspective to the assessment of treatment outcomes
following exercise interventions.

Methods
Study design and participants

In this cross-sectional study, a convenience sample of 26
volunteers was recruited from a local sleep medicine
clinic and local community; 13 patients with OSA and
13 healthy adults participated in this study. Patients who
met the inclusion criteria were enrolled in the study and
invited to the functional performance laboratory at the
George Mason University. An overnight diagnostic polysomnography (PSG) assessment was completed within 5
years of enrollment of participants in the study and was
used to determine the presence of OSA and sleep

Fig. 1 Conceptual framework that illustrates the hypothetical relationship between obstructive sleep apnea and Walking performance
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parameters. The severity of OSA was determined using
the apnea-hypopnea index (AHI), which measures the
number of apneas and hypopneas (10 s or longer per
event) that occur per hour of sleep.
The participants in this study were adults between the
ages of 25 and 60 years, with a body mass index (BMI)
between 25 and 39 kg/m2, who had undergone a recent
third-party sleep study with an AHI of 5 or greater; who
were capable of walking on an exercise treadmill; were
non-smokers; and were free of cardiovascular, metabolic,
and lung disease. Participants who reported that they
had been or were presently being treated by a physician
for any form of cardiovascular, pulmonary, or metabolic
disease and/or had any blood clotting history or vascular
disease were excluded from this study. Participants were
also required to answer no to all questions on the
Physical Activity Readiness Questionnaire (PARQ+) and
not be at high risk for a cardiac event as determined by
the health history questionnaire and the American
College of Sports Medicine (ACSM) risk assessment
model (American College of Sports Medicine 2018).
Each study participant underwent a standard assessment of height, weight, and body mass index, as well as
neck and abdominal circumference measurement, resting heart rate, and blood pressure measurement. Body
composition was examined using bioimpedance analysis
(Tanita Corp., Tokyo, Japan).
Ethical consideration

The research protocol was approved by the relevant institutional review boards of the George Mason University
prior to initiation. Obtaining written informed consent
from each participant was a condition for enrollment in
the study in accordance with the Declaration of Helsinki
(General Assembly of the World Medical 2014).
Physical activity questionnaire

Weekly physical activity status was determined by using
the seven-day Physical Activity Recall Questionnaire
(PARQ) (Hayden-Wade et al. 2003; Sallis et al. 1997).
Physical activity (PA) status and total duration of PA
were determined for all participants.
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Cardiopulmonary exercise testing

The participants were required to visit the laboratory on
two separate occasions. During the first visit, the peak
oxygen consumption and anaerobic threshold (AT) were
determined. Additionally, the participants underwent a
maximal integrated cardiopulmonary exercise test
(ICPET) on the treadmill using an individualized ramp
protocol. The workload of the treadmill protocol was
pre-determined on the basis of each participant’s body
weight and height and their self-selected comfortable
walking speed (Myers et al. 1992). ICPET was performed
on a Medgraphics® indirect calorimetry gas analysis
system (Cardio2, St. Paul, MN) for gas exchange
measurements. CPET test preparation followed the
guidelines of the American College of Sports Medicine
(ACSM) (American College of Sports Medicine 2018).
AT was determined using the following criteria: 1) the
V-slope method, defined as the inflection point from linearity of carbon dioxide output (VCO2) against oxygen
uptake (VO2) panel; 2) point of increase in end-tidal
oxygen tension (PETO2); and 3) point of increase in the
ventilatory equivalent of oxygen (VE/VO2) and a concomitant reduction of end tidal carbon dioxide (PETCO2)
(Beaver et al. 1986; Marcus et al. 1971; Wasserman et al.
1973). The primary data obtained from the motorized
treadmill exercise test included peak oxygen uptake
(VO2peak) and VO2-at-anaerobic threshold (AT) from
pulmonary gas exchange analysis. Heart rhythm and rate
were assessed using continuous electrocardiogram (ECG)
monitoring throughout the exercise testing.

Constant work rate test (CWRT)

The second visit was scheduled within 3–5 days of the
first visit. Submaximal exercise included three square
wave tests on a motorized treadmill at an exercise intensity identical to 85% of AT using the metabolic equation
of ACSM to calculate the speed and grade. The test
began with 3 min rest followed by performing 3 bouts of
constant work rate (CWR) transition from rest to work
rate at 80% of AT with each bout separated by an 8-min
active recovery at a speed of 1 mph (Fig. 2).

Fig. 2 Schematic illustration of constant work rate (CWR) test at 85% of Anaerobic Threshold (AT) during the second visit to the functional
performance lab
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Oxygen uptake (VO2) and walking speed at AT were
determined. The net VO2 (VO2net, mL/kg/min) was
calculated by subtracting the resting value of VO2 from
the VO2 at a steady state work rate during treadmill
exercise that corresponded to 85% of the AT (VO2net
= VO2Exercise − VO2Resting) (Ludlow and Weyand 2017).
Steady state VO2 was calculated by averaging the last 2min VO2 values of three consecutive 6-min bouts. The
energy cost of walking during submaximal exercise
corresponded to 85% of the AT.
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differences in FAC, the energy cost of walking, and net
VO2 emerged between the two groups, using weight, BMI,
and age as covariates in the model. Multiple linear regression corrected for weight, age, and BMI was conducted to
examine the associations between VO2peak (mL.kg− 1.
min− 1), 10MWT distance (m), and energy cost of walking
(mL.kg− 1.min− 1), treadmill energy cost of walking, and
AHI. Statistical significance was set at p ≤ 0.05. All data
analyses were conducted using the STATA version 16
statistical program (StataCorp, College Station, Texas 77,
845 USA).

Over-ground 10-min walking test (10MWT)

Participants were instructed to walk as far as possible
around a 25-m indoor walking track for 10 min. The distance covered was recorded every 2.5 min and after 10
min. The target for this test was the completion of 10
min of walking. The participants were encouraged to
complete the test without stopping. Walking performance during the 10MWT was expressed as the total distance covered in 10 min, walking speed, and the energy
cost of walking. The energy cost of over-ground walking
is known as the amount of oxygen a person consumes
per kilogram of body weight per distance traveled. For
the present study, it was derived from the 10MWT and
calculated as the amount of VO2 over the speed, where
the speed was defined as the distance walked in 10 min
VO2
(Energy cost of walking ¼ Speed
Þ (that is, mL. kg− 1. m− 1)
(Waters and Mulroy 1999).
Statistical analysis

An estimated sample size calculation was based on
detecting a difference of 8.8 ml/kg/min on peak oxygen
consumption, a standard deviation of 6.3 and estimated
for 80% power (Rizzi et al. 2013). Therefore, the estimated sample size was calculated to be at least eight
subjects per group. Convenience sampling, which is a
non-probability sampling, was performed during the
recruitment. The participants were recruited through
fliers or pamphlets in the support group or clinical center
consisting of people easy to contact or reach.
For descriptive purposes, the data is presented as mean
and standard deviation. After testing for normality,
statistical comparisons were made between the OSA and
non-OSA groups (comparison group). The indices used to
determine physiological aerobic capacity were VO2peak and
VO2-at-AT, whereas net VO2 and energy expenditure were
obtained from the CWR protocol. Functional walking outcome variables were derived from the 10MWT, including
gait speed over 10 min (meters/m) and over-ground walking energy expenditure (mL.kg− 1.m− 1), and distance (m).
The baseline characteristics of the two groups were compared using an independent t-test. Analysis of covariance
(ANCOVA) was used to determine whether significant

Results
Among 26 participants, 13 with OSA had an average AHI
of 45 ± 28, and the mean age, weight, and BMI was
47.53 ± 9.6 years, 88 ± 1Kg, and 29 ± 5 kg/m2, respectively.
The non-OSA group also consisted of 13 individuals with
a mean age, weight, and BMI of 40 ± 9 years, 67 ± 11 kg,
and 23 ± 3 kg/m2, respectively. A majority of OSA participants (69%) had severe AHI, 15% had moderate AHI, and
15% had mild AHI. Participants in both groups underwent
treadmill CPET at both maximal and sub-maximal intensity of 85% of AT. Six of the 13 OSA participants were
continuous positive airway pressure (CPAP) users. The
baseline physical and demographic characteristics of the
participants are provided in Table 1. There were no significant differences in the baseline values between the two
groups other than their weight. The physical activity level
obtained through 7-PAR did not detect differences between the two groups (p = 0.64) (Table 1).
Table 1 Demographic and physical characteristics of the study
population
Variables

OSA
n = 13

Non-OSA
n = 13

p-value

Mean ± SD Mean ± SD
Weight (kg)

87.62 ±
19.4

68.93 ±
11.27

0.006*

Height (cm)

172.15 ±
6.8

169.46 ± 8.9

NS

BMI (cm2/kg)

29±5

24±3

0.002*

Age (years)

47.53 ± 9.6

40.46 ± 8.8

NS

Resting HR (b/min)

74.22 ± 7.3

77.11 ±14.68 NS

Gender (M: F)

9:4

10:3

NS

RER at VO2 peak

1.23 ± 0.09

1.24 ± 0.09

NS

Resting VO2(mL/kg/min)

3.5 ± 0.78

3.85 ± 1.35

NS

Sleep duration (Hours/Week)

49±6

51±5

NS

7-day Physical activity recall
(METs)

7.5±3.4

8±3.1

NS

Values are expressed as Mean (SD) or frequency
Abbreviation: OSA Obstructive Sleep Apnea, VO2 oxygen uptake, RER
respiratory exchange ratio, NS not significant
*Denotes statistically significant p ≤ 0.05
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The data on maximal cardiopulmonary capacity is
presented in Table 2. There were significant differences
in VO2peak (OSA 29.69 ± 5.6 mL/kg/min vs. non-OSA
37.49 ± 6.5 mL/kg/min, p = 0.03). Compared to the nonOSA group, the OSA participants had significantly (P <
0.001) lower walking performance, and OSA patients
tended to have higher energy cost of walking compared
to the non-OSA group, as well as higher energy expenditure (Table 3). The VO2 net of the participants with OSA
during CWR was significantly lower than that of the nonOSA participants after controlling for age, weight, BMI,
and speed m/min (13 ± 6 vs. 19 ± 5, p = 0.02). In Table 3,
the distance covered during the 10MWT was significantly
lower for the OSA participants than for the non-OSA
participants (p < 0.001). During submaximal exercise, the
oxygen pulse VO2/HR (mL O2/beat) of OSA group was
not significantly different from that of non-OSA group
(11.70 ± 3.31 vs. 19 ± 5, 10.56 ± 2.85, p = 0.1).
A majority of patients with OSA did not use CPAP
(7[54]) and only 6 patients used CPAP (6[46%]). The
findings showed that there was no significant difference
in the metabolic cost of walking (p = .45) and peak
oxygen consumption (p = .8) between CPAP users and
non-CPAP-users.
A multiple regression model adjusted for confounders,
including age, weight, and BMI, was used to assess the
association between energy cost of walking, 10MWT
speed, distance, VO2peak, and AHI severity. The findings
showed that AHI significantly predicted the energy cost
of walking (F = 27.6, p < 0.001, R2 = 0.87) and AHI explains 87% of variance in the energy cost of walking
during the 10MWT. There was a lack of significant
association between VO2peak and AHI severity (P = 0.4).
The significant associations between AHI and walking
Table 2 Comparison of cardiopulmonary variables at peak
exercise of the study population
Variables

Table 3 Outcome of walking economy during submaximal
exercise and 10-min walk test (10 MWT) among the study
groups
Variables

OSA
(n = 13)

Non-OSA
(n = 13)

Mean ± SD

Mean ± SD

p-value

10MWT VO2 (mL/kg/min)

11.27 ± 0.48

14.45 ± 0 .80

< 0.001*

10 MWT Speed (m/min)

178 ± 5

110 ± 8

< 0.001*

10 MWT Distance (m)

777.48 ± 48

1095.64 ± 83

< 0.001*

10 MWT Energy cost of
walking (mL/kg/m)

0.14 ± 0.003

0.13 ± 0.002

< 0.001*

Energy cost of CWR (mL/kg/m) 0.019 ± 0.003 0.015 ± 0.004 0.0007
CWR VO2/HR (mL O2/beat)

11.70 ± 3.31

10.56 ± 2.85

0.1

Value are means± SD
ANCVOA testing were used corrected for the age, weight, BMI
Abbreviation: AT anaerobic threshold, CWR constant work rate, HR heart rate
*denote statistically significant p ≤ 0.05

speed, distance, and VO2 at the anaerobic threshold
(p < 0.001) is presented in Table 4.

Discussion
A major finding of this study is that OSA participants
had impaired walking performance and aerobic walking
capacity when compared to non-OSA adults. Our results
indicate that the metabolic cost of walking was high in
the OSA group compared to the control group, and their
maximal oxygen consumption was reduced by comparison. The severity of OSA, as reflected by AHI, was found
to be associated with the rate of oxygen consumption at
AT, which is a robust predictor of aerobic exercise performance. There was a significant relationship between
OSA severity (AHI) and the energy cost level of walking,
walking distance, and net VO2 during the submaximal
treadmill test. Collectively, these findings indicate that
individuals with more severe OSA are more likely to
expend more energy when completing activities of daily

p-value

OSA
(n = 13)

Non-OSA
(n = 13)

Mean ± SD

Mean ± SD

Time to AT (min)

7.0 ± 1.41

8.11 ± 2.44

0.1

Table 4 The Multiple linear regression analyses for the
association between VO2 and walking performance variables
during 10 MWT and AHI of the study population

VO2 at AT (mL/kg/min)

19 ± 5

25 ± 6

0.05

Variables

Test Duration (min)

10.2 ± 1.5

10.8 ± 2.7

AHI

p-value

2

R

0.08

VCO2 (mL/min)

2967 ± 763

2983 ± 717

0.3

VO2peak (mL/kg/min)

PETO2

115 ± 3

115 ± 6

0.2

VO2-at-AT

0.92

< 0.001*

PETCO2

32 ± 2

31 ± 4

0.5

10MWT distance (m)

0.85

< 0.001*

HRPeak (b/min)

160 ± 13

167 ± 21

0.9

10MWT speed (m/min)

0.85

< 0.001*

VE/VO2Peak ratio (no unite)

31 ± 4.2

37 ± 6.3

0.6

Energy cost of walking (mL/kg/min)

0.87

< 0.001*

VE/VCO2Peak ratio (no unite)

25 ± 6.6

29 ± 3.6

0.03

Treadmill energy cost of walking

0.59

0.04*

VO2/HRPeak (mL O2/beat)

17.92 ± 5.4

17.46 ± 5.6

0.2

Value are means± SD
Abbreviation: AHI apnea hypopnea index, VO2-at-AT oxygen consumption at
anaerobic threshold
ANCVOA testing were used corrected for the age, weight, BMI
*Denotes p-value ≤ 0.05 for the correlation coefficients

Value are means± SD
Abbreviation: AT anaerobic threshold, CWR constant work rate, HR heart rate
ANCVOA testing were used corrected for the age, weight, BMI

0.45

0.4
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living, which may increase the perception of fatigue. In
this study, the lack of significant difference between
OSA and non-OSA participants in ventilatory efficiency
(VE/VO2 and VE/CO2 slope) and peak and submaximal
oxygen pulse (VO2/HR is used as a proxy for ventilatory
and cardiac performance) suggests that the role of the
cardiopulmonary response to exercise was not a limiting
factor in the walking performance of participants.
Existing literature evaluating the cardiopulmonary response to exercise in OSA patients using a motor-driven
treadmill reports conflicting results. In several studies,
there was no difference in the maximal exercise capacity
between healthy adults and OSA patients (Mortari et al.
2014; Flore et al. 2006). This contradictory finding may
be attributed to selection criteria for study participants
(who were newly diagnosed with OSA), the presence of
comorbidities, and varying levels of OSA severity that
may limit the generalizability of results (Flore et al.
2006). In line with our findings, other studies investigating the response to exercise testing of OSA patients have
shown a decrease in exercise capacity (Lin et al. 2006;
Nanas et al. 2010; Ucok et al. 2009; Vanhecke et al.
2008; Vanuxem et al. 1997). As expected, the value of
peak oxygen consumption reported in this study was
within the reference range (29.6 ± 6 mL/kg/min) for the
OSA population reported previously (Mortari et al.
2014). Systematic reviews show that reduction in
VO2peak was larger in non-obese patients (body mass
index < 30 kg/m2), similar to our participant group
(Berger et al. 2019; Mendelson et al. 2018).
There are a number of etiological factors by which
OSA may appear to reduce the functional aerobic capacity and influence the energy cost of walking in people
with severe obstructive sleep apnea. Sleep fragmentation
and daytime somnolence are known to influence aerobic
capacity, which may partially contribute to the reported
decline in exercise tolerance and increase in the energy
cost of walking in patients with OSA (Hong and Dimsdale 2003; Martin 1981; Mougin et al. 1991). A potential
physiological mechanism that was not analyzed due to
methodological limitations was decrease in maximal
lactate concentration and delayed lactate elimination.
This has been reported previously in OSA compared to
age-matched controls, which may suggest impaired
glycolytic and oxidative metabolism (Vanuxem et al.
1997). The findings of previous studies may explain the
reported impairment of functional aerobic capacity of
OSA patients.
The findings of exercise intolerance in our study demonstrated that the high energy cost of walking and decreased
speed and distance in OSA patients may contribute to excessive daytime somnolence. A number of observational
studies have revealed diminished exercise performance
among OSA patients under the influence of sleep
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deprivation (Aguillard et al. 1998; Martin 1981; Van Helder
and Radomski 1989). Extreme daytime somnolence in
healthy men has been shown to reduce tolerance to tasks
and increase the rating of perceived exertion during exercise testing (Temesi et al. 2013). Therefore, we cannot exclude the possibility of influence of sleep deprivation on the
performance of the OSA participants in our study. Among
several factors that must be considered are delayed clearance of post-exercise lactate in OSA patients and increased
concentration of catecholamines. It has been reported that
in OSA, the lactate threshold was attained at lower workload levels compared to age- and weight-matched controls,
and an abnormal build-up of lactate was directly related to
exercise capacity (Bonanni et al. 2004). These findings
could be explained, at least in part, by the lower oxidative
capacity of the muscle that promotes increased reliance on
anaerobic metabolism in patients with OSA. Although local
muscle metabolic impairment is not clearly understood, it
would support both an early onset of metabolic acidosis
and a subsequent increase in perceived fatigue (Keyser
2010). Vanuxem et al. (1997) reported a slow rate of lactate
elimination, which could indicate a primary defect in oxidative metabolism secondary to the repeated events of
nocturnal hypoxemia. Unfortunately, lactate concentration
was not assessed in our study and would require further
evaluation. Furthermore, repetitive cycles of hypoxemia and
reoxygenation induce autonomic system instability which
diminishes aerobic performance through changes in the
muscle bioenergetic response (Bonanni et al. 2004;
Vanuxem et al. 1997). Several studies have demonstrated
structural changes in skeletal muscle fibers and bioenergetic
system of the active muscle parallel to the modulation observed in chronic hypoxia conditions (Beitler et al. 2014;
Sauleda et al. 2003). Abnormalities of the skeletal muscles,
such as structural and bioenergetic changes in the skeletal
muscle fibers (Sauleda et al. 2003), identified in OSA patients in a previous muscle biopsy study, may contribute to
their lower maximal exercise capacity. Lower net VO2 during submaximal exercise may, in part, be explained by the
recruitment of glycogenolytic fibers that occurs at lower
levels of muscle contraction (Chwalbinska-Moneta et al.
1989). Reduced resistance to fatigue in these patients could
be related to an increase in the energy cost of walking and
decrease in the workload even after controlling for confounders, such as weight, BMI, and speed in the analysis.
In this study, it must be highlighted that the differences in body composition between the groups may rationalize some of the unexplained variance in walking
performance and aerobic capacity. Studies in the broader
literature have investigated the association between
biomechanical modifications in gait characteristics and
variations in body mass distribution (Ko et al. 2010;
Maciejczyk et al. 2014). Walking in overweight or obese
individuals may be affected by the body composition. It
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has been demonstrated that obese individuals with
excess body weight exhibit shorter stride lengths, slow
gait speed, and impaired aerobic capacity (Pataky et al.
2014). Further analysis in this study was performed
between patients with OSA who had high BMI (n = 8)
and patients with OSA who had normal body weight.
The findings demonstrated no significant differences
(p > 0.05) in the energy cost of walking, 10MWT speed,
distance, and VO2peak.
Previous findings related to the association between
OSA severity and physical performance are generally
consistent with our results. In a study by Billings et al.
(2016), low level of recreational activity such as walking
was correlated with greater severity of sleep apnea, defined by using the apnea-hypopnea index, especially in
male and obese individuals. Our findings suggest that
the severity of OSA may contribute to some extent to an
increase in the energy cost of walking and lower VO2 at
CWR independent of age, weight, and BMI. This is also
supported by a study by Mansukhani et al. (2013), which
offers robust evidence that the severity of sleep-related
breathing is associated with FAC.
Our study has a few limitations. First, the crosssectional design of our study did not allow us to establish
a causal relationship. Second, some of the participants in
the OSA group used CPAP, which could confound our results. However, there is conflicting evidence on the effect
of long-term use of CPAP on exercise capacity. It has been
previously reported that nocturnal use of CPAP improves
exercise tolerance and dyspnea in obese patients with
OSA (Pendharkar et al. 2011). On the contrary, other
studies have reported contradictory findings that CPAP
treatment did not change the peak oxygen consumption
(VO2peak). To some extent, our findings may have been
influenced by 20% of patients who were using CPAP. Despite this, differences between OSA and non-OSA participants in walking speed and mechanical efficiency were
significant. However, future research should account for
the influence of CPAP. Another limitation of this study
was the weight of the OSA patient, as the findings of our
study maybe partly influenced by the weight of the OSA,
which may influence the gait characteristic in our sample.
However, the difference in this study between lean and
obese patients with OSA did not reveal any significant difference in the energy cost of walking, 10MWT speed, distance, and VO2peak, which may rule out the potential
effect of weight on the outcome of interest. Moreover, we
accounted for visceral obesity and fat distribution in this
study by using weight and BMI as confounders in the
statistical analysis, yet there may be unknown confounders
associated with obesity that we did not control. Additionally, PSG for sleep apnea was performed within 5 years in
two of the patients with OSA and AHI was mild, and the
remining were subjected to the test within 3–6 months.
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The timing effect may create variability in apneahypopnea index (AHI). Nevertheless, readers should interpret the results with that limitation in mind. Finally, the
low number of participants and limitation of this study to
one research center may have interfered in the findings
and made it difficult to extrapolate the data.

Conclusions
The main findings in this study are that patients with
OSA exhibited an increased energy cost of walking and
reduced functional aerobic capacity during walking compared to non-OSA adults. The OSA patients tended to
show less mechanical efficiency, as evidenced by their
lower net VO2 at the anaerobic threshold. Walking
performance during 10MWT, presented as speed and
distance covered, was lower in OSA participants,
whereas the energy cost of walking was higher. This indicates that individuals with OSA tend to expend more
energy to accomplish activities of daily living, which may
reduce their level of physical activity and increase their
perception of fatigue. The impairment of walking economy among OSA patients might take a toll on the physical
function status and cardiovascular health. The study of
movement economy and FAC response in patients with
OSA is physiologically relevant to understand the adaptive
changes that occur in response to hypoxia-reoxygenation
episodes during sleep. Future studies need to elucidate the
mechanisms involved in the response of walking economy
to various targeted interventions. Moreover, investigative
approaches using muscle biopsy or infrared spectroscopy
(NIRS) could profoundly characterize muscle oxidative
capacity and functional aspects of the skeletal muscle in
this context and shed light on impaired exercise tolerance
in OSA.
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